| A multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice AW Freyn, JR da Silva, VC Rosado, CM Bliss, M Pine, BL Mui, YK Tam, ... Molecular Therapy 28 (7), 1569-1584, 2020 | 216 | 2020 |
| Broadly neutralizing antibodies target a haemagglutinin anchor epitope JJ Guthmiller, J Han, HA Utset, L Li, LYL Lan, C Henry, CT Stamper, ... Nature 602 (7896), 314-320, 2022 | 86 | 2022 |
| A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses W Sun, Y Liu, F Amanat, I González-Domínguez, S McCroskery, ... Nature communications 12 (1), 6197, 2021 | 67 | 2021 |
| An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults AT Widge, AR Hofstetter, KV Houser, SF Awan, GL Chen, ... Science translational medicine 15 (692), eade4790, 2023 | 25 | 2023 |
| Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice AW Freyn, M Pine, VC Rosado, M Benz, H Muramatsu, M Beattie, YK Tam, ... Molecular Therapy Methods & Clinical Development 22, 84-95, 2021 | 17 | 2021 |
| Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes AW Freyn, J Han, JJ Guthmiller, MJ Bailey, K Neu, HL Turner, VC Rosado, ... Proceedings of the National Academy of Sciences 118 (8), e2018102118, 2021 | 9 | 2021 |
| Eliciting a single amino acid change by vaccination generates antibody protection against group 1 and group 2 influenza A viruses R Ray, FAN Mohamed, DP Maurer, J Huang, BA Alpay, L Ronsard, Z Xie, ... Immunity 57 (5), 1141-1159. e11, 2024 | | 2024 |
